Conisha Holloman MD
Maternal & Fetal Medicine/High Risk
Maternal-Fetal Medicine
Join to View Full Profile
6651 Main StreetSuite 1020Houston, TX 77030
Phone+1 832-826-7375
Dr. Holloman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Conisha Holloman is an Obstetrics and Gynecology specialist based in Houston, TX, with subspecialty training in Maternal and Fetal Medicine, particularly focused on high-risk pregnancies. She completed her residency at Orlando Health in Obstetrics and Gynecology and her fellowship in Maternal-Fetal Medicine at the University of Texas Health Science Center at Houston (Memorial Hermann Hospital). She graduated from the University of Rochester School of Medicine and Dentistry in 2014. Dr. Holloman has authored several publications, including studies on high titer autoantibodies, severe preeclampsia in fetal growth-restricted pregnancies, the impact of maternal obesity on perinatal outcomes, and management of preterm prelabor rupture of membranes. Her research has been cited multiple times in the medical literature.
Education & Training
University of Texas Health Science Center at Houston (Memorial Hermann Hospital)Fellowship, Maternal-Fetal Medicine, 2018 - 2021
Orlando HealthResidency, Obstetrics and Gynecology, 2014 - 2018
University of Rochester School of Medicine and DentistryClass of 2014
Certifications & Licensure
OH State Medical License 2025 - 2027
GA State Medical License 2025 - 2026
KS State Medical License 2025 - 2026
KY State Medical License 2025 - 2026
TX State Medical License 2018 - 2026
AL State Medical License 2024 - 2025
American Board of Obstetrics and Gynecology Obstetrics & Gynecology- American Board of Obstetrics and Gynecology Maternal-Fetal Medicine
Publications & Presentations
PubMed
- 23 citationsProspective Evaluation of High Titer Autoantibodies and Fetal Home Monitoring in the Detection of Atrioventricular Block Among Anti-SSA/Ro Pregnancies.Jill P Buyon, Mala Masson, Caroline G Izmirly, Colin Phoon, Ruben Acherman
Arthritis & Rheumatology. 2024-03-01 - 5 citationsImpact of Maternal Obesity on Perinatal Outcomes in Preterm Prelabor Rupture of Membranes ≥34 Weeks.Tara A. Lynch, Amol Malshe, Sarah Colihan, Jeffrey M. Meyers, Dongmei Li
American Journal of Perinatology. 2020-04-01 - 4 citationsPreterm Prelabor Rupture of Membranes: Outcomes with Expectant Management until 34 versus 35 Weeks.Tara A. Lynch, Courtney Olson-Chen, Sarah Colihan, Jeffrey M. Meyers, Conisha Holloman
American Journal of Perinatology. 2019-06-01
Journal Articles
- 957 Obstetric Outcomes in Patients Undergoing Expectant Management for Severe Preeclampsia in Fetal Growth-Restricted PregnanciesConisha M Holloman, Cara Buskmiller, Baha M Sibai, American Journal of Obstetrics and Gynecology
Press Mentions
OB-GYNs Step up Preeclampsia Prevention by Recommending Low-Dose Aspirin for All PatientsFebruary 13th, 2020
Study Says Women with Preeclampsia Are More at Risk for Heart DiseaseFebruary 7th, 2020
All Women Should Be Educated After Childbirth About High Blood PressureFebruary 6th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
